Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$16,593,017
+$3,102,859 QoQ
Shares Held
824,293
-1.3% QoQ
Ownership
1.55%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 182 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 99.98240916761394.ToString("F0")%
Shared 0.ToString("F0")%
None 0.0175908323860569.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Derivatives in KALV
reported options exposure · as of Dec 31, 2023CallValue
$2,984,100
CallShares
243,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. KALV ranks #114 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in KALV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,593,017 | 824,293 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,490,158 | 835,304 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $21,926,203 | 1,800,181 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,519,369 | 134,398 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,922,860 | 339,936 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $2,775,390 | 327,673 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,552,193 | 134,041 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,507,820 | 212,888 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $709,595 | 59,831 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,066,962 | 87,099 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,984,100 | 243,600 | Call | Defined | 2024-05-14 | |
| 2023-09-30 | $2,010,858 | 208,812 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $2,639,799 | 293,311 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $2,165,304 | 275,484 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $2,336,964 | 345,705 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $4,906,991 | 338,180 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $2,964,545 | 301,275 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $2,457,231 | 166,705 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,315,471 | 99,431 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $1,209,197 | 69,295 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $757,375 | 31,610 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,402,648 | 54,599 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $200,724 | 10,570 | Shares | Defined | 2021-02-12 | |
| 2020-06-30 | $445,050 | 36,781 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||